Litcius/Paper detail

The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study

Ping‐Fang Hu, Xin Zeng, Ziyuan Zou, Wei Tang, Yibin Guo, Zong-Li Yuan, Pei‐Mei Shi, Yu Ting Tan, Yan Song, Yongquan Shi, Wei‐Fen Xie

2021HepatoBiliary Surgery and Nutrition32 citationsDOIOpen Access PDF

Abstract

BACKGROUND: With lifestyle modification and over-nutrition, the prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing annually. Here we aimed to assess the updated prevalence of NAFLD, and to evaluate the association of NAFLD with metabolic abnormalities according to gender, body mass index and age. METHODS: A population-based cross-sectional study was conducted in Shanghai from December 2016 to July 2017. With a three-stage stratified sampling strategy, 3,717 eligible participants were enrolled for the analysis. RESULTS: In total, 1,217 subjects (32.7%) had NAFLD. Among them, 400 (16.3%) of the nonobese and 817 (65.0%) of the obese subjects had NAFLD. The prevalence of NAFLD was increased according to the quartiles of age and waist circumference (WC) in the nonobese subjects. Females with nonobese NAFLD had 1.6-, 2.6-, 2.0-, 2.3- and 3.3-fold higher risks for metabolic syndrome, diabetes mellitus, hyperglycemia, hypertriglycerdemia (high TG) and low high-density lipoprotein cholesterol than obese subjects without NAFLD, respectively. Males had comparable metabolic profiles in both groups, except for a 2.0-fold higher risk of high TG in nonobese NAFLD subjects compared with obese subjects without NAFLD. More impressively, the homeostasis metabolic assessment insulin resistance index was comparable between the two groups. CONCLUSIONS: The increase of age and WC had significant impact on the risk of NAFLD in nonobese subjects. The presence of NAFLD in nonobese subjects increased the risk of metabolic diseases than obese subjects without NAFLD, especially in female.

Topics & Concepts

MedicineInternal medicineNonalcoholic fatty liver diseaseMetabolic syndromeBody mass indexInsulin resistanceWaistObesityFatty liverDiabetes mellitusPopulationCross-sectional studyEndocrinologyGastroenterologyDiseasePathologyEnvironmental healthLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and Outcomes